Little change of modifiable risk factors 1 year after stroke: A pilot study

International Journal of Stroke

Volumn 5, Issue 3, 2010, Pages 157-162

  Hornnes, Nete ^a   Larsen, Klaus ^b   Boysen, Gudrun ^c  

^a HVIDOVRE HOSPITAL   (Denmark)

^b H LUNDBECK A S   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Follow up; Health behaviour; Hypertension; Risk factors; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CIGARETTE SMOKING; FEASIBILITY STUDY; FEMALE; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STROKE; STROKE PATIENT; STROKE UNIT; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BLOOD PRESSURE; CHOLESTEROL; DENMARK; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MOTOR ACTIVITY; PATIENT COMPLIANCE; PILOT PROJECTS; RECURRENCE; RISK FACTORS; SMOKING; SMOKING CESSATION; STROKE;

EID: 77953730760     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00424.x     Document Type: Article

References (27)

1. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study. Neurology 1997, 48:891-5.
2. Spolaore P, Brocco S, Fedeli U. Measuring accuracy of discharge diagnoses for a region-wide surveillance of hospitalized strokes. Stroke 2005, 36:1031-4.
3. Broderick J, Brott T. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998, 29:415-21.
4. Sacco RL. Identifying patient populations at high risk for stroke. Neurology 1998, 51((Suppl. 3)):S27-30.
5. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 2000, 342:145-53.
6. Friday G, Alter M, Lai SM. Control of hypertension and risk of stroke recurrence. Stroke 2002, 33:2652-7.
7. trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033-41. Progress Collaboration Group. Randomised
8. Ovbiagele B, Hills NK, Saver JL, Johnston SC. Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event. Stroke 2005, 36:1944-7.
9. Frank J. Managing hypertension using combination therapy. Am Fam Physician 2008, 77:1279-86.
10. Johnson P, Rosewell M, James MA. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy? Cerebrovasc Dis 2007, 23:156-61.
11. Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke 2002, 33:1656-9.
12. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003, 34:2741-8.
13. Qureshi AI, Suri MF, Guterman LR, Hopkins LN. Ineffective secondary prevention in survivors of cardiovascular events in the US population: report from the third national health and nutrition examination survey. Arch Intern Med 2001, 161:1621-8.
14. Kernan WN, Viscoli CM, Brass LM, Makuch RW, Sarrel PM, Horwitz RI. Blood pressure exceeding national guidelines among women after stroke. Stroke 2000, 31:415-9.
15. Zanchetti A, Hansson L, Dahlof B. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the hypertension optimal treatment study HOT study group. J Hypertens 2001, 19:1149-59.
16. Lindenstrøm E, Boysen G, Christiansen LW, Rogvi-Hansen B, Nielsen BW. Reliability of scandinavian stroke scale. Cerebrovasc Dis 1991, 1:103-7.
17. Andersen LB, Schnohr P, Schroll M, Hein HO. All-cause mortality associated with physical activity during leisure time, work, sports, and cycling to work. Arch Intern Med 2000, 160:1621-8.
18. Tonarelli SB, Vazquez G, Peacock JM. Stroke prevention: the best outcome after a transient ischemic attack. Results from the minnesota stroke registry and opportunities to improve care. J Vasc Intervent Radiol Neurol 2008, 1:118-21.
19. Paul SL, Thrift AG. Control of hypertension 5 years after stroke in the North East Melbourne Stroke Incidence Study. Hypertension 2006, 48:260-5.
20. Kaplan RC, Tirschwell DL, Longstreth WT. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology 2005, 65:835-42.
21. Phillips LS, Branch WT, Cook CB. Clinical inertia. Ann Intern Med 2001, 135:825-34.
22. Calhoun DA, Jones D, Textor S. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure research. Circulation 2008, 117:e510-26.
23. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav 2006, 10:227-45.
24. Kaplan RC, Bhalodkar NC, Brown EJ, White J, Brown DL. Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Prev Med 2004, 39:1249-55.
25. Touze E, Coste J, Voicu M. Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention: IMplementation of Prevention after a Cerebrovascular evenT (IMPACT) study. Stroke 2008, 39:1834-43.
26. Truelsen T, Gronbaek M, Schnohr P, Boysen G. Intake of beer, wine, and spirits and risk of stroke: the Copenhagen city heart study. Stroke 1998, 29:2467-72.
27. Bak S, Sindrup SH, Alslev T, Kristensen O, Christensen K, Gaist D. Cessation of smoking after first-ever stroke: a follow-up study. Stroke 2002, 33:2263-9.